# Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis

> **NCT01860664** · PHASE2 · TERMINATED · sponsor: **Koffler Vision Group** · enrollment: 15 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** hydrocortisone ophthalmic ointment 0.5%
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01860664
- **Lead sponsor:** Koffler Vision Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-05
- **Primary completion:** 2016-05
- **Final completion:** 2017-01-01
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** The Sponsor has stopped responding to calls and emails
- **Last updated:** 2017-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01860664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01860664, "Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01860664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*